30 Nov 2020 --- US-based nutraceutical manufacturer Sabinsa has uncovered an ingredient falsely marketed as amla-derived vitamin C in its ongoing efforts to remove adulterated additives from the market. The company submitted evidence to the US Food and Drug Administration (FDA) and Federal Trade Administration (FTA) that an ingredient sold as vitamin C derived from amla fruit was in fact derived from corn, sugar cane or other plants. Two independent laboratories confirmed the results.
